Q-linea AB (publ)
SSE:QLINEA.ST
Overview | Financials
Company Name | Q-linea AB (publ) |
Symbol | QLINEA.ST |
Currency | SEK |
Price | 2.49 |
Market Cap | 290,925,445 |
Dividend Yield | 0% |
52-week-range | 2.4 - 11.2 |
Industry | Medical Instruments & Supplies |
Sector | Healthcare |
CEO | Dr. Jonas Jarvius Ph.D. |
Website | https://www.qlinea.com |
An error occurred while fetching data.
About Q-linea AB (publ)
Q-linea AB (publ) engages in the development of instruments and consumables for infection diagnostics in Sweden. It offers inventive systems for in vitro diagnostics systems for infectious diseases. The company's lead product candidate is ASTar, an antibiotic susceptibility testing system used for positive blood cultures. It develops and delivers solutions
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD